Market Cap (In KRW)
72.82 Billion
Revenue (In KRW)
137.2 Billion
Net Income (In KRW)
-7.18 Billion
Avg. Volume
84.35 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 3900.0-6730.0
- PE
- -
- EPS
- 0.0
- Beta Value
- 0.503
- ISIN
- KR7000220004
- CUSIP
- -
- CIK
- -
- Shares
- 16182721.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Wonsang Yu
- Employee Count
- -
- Website
- https://www.yuyu.co.kr
- Ipo Date
- 2000-01-04
- Details
- Yuyu Pharma, Inc. develops and markets pharmaceutical products. The company offers various prescription drugs, including osteoporosis, brainbone metabolism-hypocalcemia improvement, cerebral and peripheral circulatory disturbance, tromboembolism, respiratory organ, hypertension, pulmonary tuberculosis therapy, arthrifuge, diabetic neuropathy therapy, eczematous dermatitis drugs, and other circulatory system drugs, as well as antibiotics and skeletal muscle relaxants. It also provides non-prescription drugs and health supplements. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Seoul, South Korea.
More Stocks
-
473050Yuanta SPAC 15
473050
-
4431Smaregi, Inc.
4431
-
OBNNFOsisko Mining Inc.
OBNNF
-
CREX
-
603078
-
FRFRFritzy Tech Inc.
FRFR
-
MTC-R
-
MINID